- ICH GCP
- Registro de ensayos clínicos de EE. UU.
- Ensayo clínico NCT07563725
Vascular Aging and Microcirculation: Physiological Aspects of Vascular Aging in the Elderly Population (VAMP-Aging) (VAMP-Aging)
Rising life expectancy worldwide challenges public health due to increased cardiovascular disease linked to vascular aging, where microvascular dysfunction serves as an early indicator of system-wide inflammation, or "inflammaging". The proposed study aims to validate non-invasive, high-resolution techniques, such as Laser Speckle Contrast Imaging, to identify early endothelial senescence biomarkers and map their correlation with metabolic, inflammatory, and anthropometric profiles to advance personalized, preventive translational medicine.
Descripción general del estudio
Estado
Condiciones
Intervención / Tratamiento
Descripción detallada
An observational, cross-sectional study will be conducted, including volunteers aged ≥ 60 years, divided into two groups: elderly (60-80 years) and very elderly (>80). Young volunteers aged between 20 and 40 years, already participants in previous studies, whose demographic and microcirculation data are in the research laboratory's database, will be included as controls. Data from the control group will be obtained from an institutional database, respecting confidentiality and anonymization, in accordance with current ethical standards.
Tipo de estudio
Inscripción (Estimado)
Contactos y Ubicaciones
Estudio Contacto
- Nombre: Eduardo Tibirica, MD, PhD
- Número de teléfono: +55-21-99914-6075
- Correo electrónico: etibi@uol.com.br
Ubicaciones de estudio
-
-
-
Rio de Janeiro, Brasil, 22240006
- Reclutamiento
- Eduardo Tibiriçá
-
Contacto:
- Eduardo Tibiriçá, MD, PhD
- Número de teléfono: 21999146075
- Correo electrónico: etibi@oul.com.br
-
-
Criterios de participación
Criterio de elegibilidad
Edades elegibles para estudiar
Acepta Voluntarios Saludables
Géneros elegibles para el estudio
Método de muestreo
Población de estudio
An observational, cross-sectional study will be conducted, including volunteers aged ≥ 60 years, divided into two groups: elderly (60-80 years) and very elderly (>80). Young volunteers aged between 20 and 40 years, already participants in previous studies, whose demographic and microcirculation data are in the research laboratory's database, will be included as controls. Data from the control group will be obtained from an institutional database, respecting confidentiality and anonymization, in accordance with current ethical standards.
Descripción
Inclusion Criteria:
- Absence of symptoms and history of cardiovascular and cerebrovascular diseases.
- Baseline blood pressure levels within the normal range (< 140/90 mmHg, according to WHO criteria) and absence of use of antihypertensive medications.
Exclusion Criteria:
- Diabetes Mellitus: Fasting blood glucose ≥ 126 mg/dL or use of hypoglycemic agents.
- Smoking: Active or quit less than 5 years ago.
- Inflammatory Diseases: Autoimmune diseases, active neoplasms, or acute infectious processes.
- Surgery or trauma in the last 60 days.
- Renal Dysfunction: Chronic renal failure (estimated by eGFR < 60 mL/min/1.73m²).
- Medication Use: Chronic use of corticosteroids, immunosuppressants, or drugs with direct action on vascular reactivity (e.g., continuous use of nitrates).
Plan de estudios
¿Cómo está diseñado el estudio?
Detalles de diseño
- Modelos observacionales: COHORT
- Perspectivas temporales: PROSPECTIVE
Cohortes e Intervenciones
Grupo / Cohorte |
Intervención / Tratamiento |
|---|---|
|
elderly (60-80 years)
Evaluation of systemic microcirculation Cognitive assessment tests Muscle strength assessment tests Life history and health questionnaire |
Investigation of Systemic Endothelial Microvascular Function Serving as a marker of systemic muscle strength and sarcopenia. This test will assess the strength and power of the lower limbs. Failure to maintain the position (to stand on one leg) for at least 10 seconds will be correlated as a marker of frailty and risk of falls. Overall cognitive function will be assessed using the Mini-Mental State Examination. |
|
very elderly (>80)
Evaluation of systemic microcirculation Cognitive assessment tests Muscle strength assessment tests Life history and health questionnaire |
Investigation of Systemic Endothelial Microvascular Function Serving as a marker of systemic muscle strength and sarcopenia. This test will assess the strength and power of the lower limbs. Failure to maintain the position (to stand on one leg) for at least 10 seconds will be correlated as a marker of frailty and risk of falls. Overall cognitive function will be assessed using the Mini-Mental State Examination. |
|
control group: healthy young people aged 20-40 years
Evaluation of systemic microcirculation Cognitive assessment tests Muscle strength assessment tests Life history and health questionnaire |
Investigation of Systemic Endothelial Microvascular Function Serving as a marker of systemic muscle strength and sarcopenia. This test will assess the strength and power of the lower limbs. Failure to maintain the position (to stand on one leg) for at least 10 seconds will be correlated as a marker of frailty and risk of falls. Overall cognitive function will be assessed using the Mini-Mental State Examination. |
¿Qué mide el estudio?
Medidas de resultado primarias
Medida de resultado |
Medida Descripción |
Periodo de tiempo |
|---|---|---|
|
Systemic (cutaneous) microcirculatory reactivity.
Periodo de tiempo: up to 20 minutes
|
To analyze structural and functional changes in the microcirculation in different ages groups, with emphasis on microvascular endothelial senescence. |
up to 20 minutes
|
Medidas de resultado secundarias
Medida de resultado |
Medida Descripción |
Periodo de tiempo |
|---|---|---|
|
Muscle Strength
Periodo de tiempo: up to 10 minutes
|
Handgrip Dynamometry Maximum isometric strength will be assessed using a manual hydraulic dynamometer. |
up to 10 minutes
|
Colaboradores e Investigadores
Investigadores
- Investigador principal: Eduardo Tibirica, MD, PhD, National Institute of Cardiology/Ministry of Health
Fechas de registro del estudio
Fechas importantes del estudio
Inicio del estudio (Actual)
Finalización primaria (Estimado)
Finalización del estudio (Estimado)
Fechas de registro del estudio
Enviado por primera vez
Primero enviado que cumplió con los criterios de control de calidad
Publicado por primera vez (Actual)
Actualizaciones de registros de estudio
Última actualización publicada (Actual)
Última actualización enviada que cumplió con los criterios de control de calidad
Última verificación
Más información
Términos relacionados con este estudio
Términos MeSH relevantes adicionales
Otros números de identificación del estudio
- VAMP-Aging
Plan de datos de participantes individuales (IPD)
¿Planea compartir datos de participantes individuales (IPD)?
Información sobre medicamentos y dispositivos, documentos del estudio
Estudia un producto farmacéutico regulado por la FDA de EE. UU.
Estudia un producto de dispositivo regulado por la FDA de EE. UU.
Esta información se obtuvo directamente del sitio web clinicaltrials.gov sin cambios. Si tiene alguna solicitud para cambiar, eliminar o actualizar los detalles de su estudio, comuníquese con register@clinicaltrials.gov. Tan pronto como se implemente un cambio en clinicaltrials.gov, también se actualizará automáticamente en nuestro sitio web. .